The treatment of traumatic shock: recent advances and unresolved questions.

about

The treatment of traumatic shock: recent advances and unresolved questions.

Item

http://www.wikidata.org/entity/Q38713175

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

The treatment of traumatic shock: recent advances and unresolved questions.

@en

type

Item

label

The treatment of traumatic shock: recent advances and unresolved questions.

@en

prefLabel

The treatment of traumatic shock: recent advances and unresolved questions.

@en

P1476

The treatment of traumatic shock: recent advances and unresolved questions.

@en

P2093

C Bendinelli

http://www.w3.org/2001/XMLSchema#string

D Dewar

http://www.w3.org/2001/XMLSchema#string

J Evans

http://www.w3.org/2001/XMLSchema#string

K King

http://www.w3.org/2001/XMLSchema#string

K Sisak

http://www.w3.org/2001/XMLSchema#string

M Miller

http://www.w3.org/2001/XMLSchema#string

N Butcher

http://www.w3.org/2001/XMLSchema#string

O Yoshino

http://www.w3.org/2001/XMLSchema#string

P Harrigan

http://www.w3.org/2001/XMLSchema#string

Z J Balogh

http://www.w3.org/2001/XMLSchema#string

P2860

Causes of death in U.S. Special Operations Forces in the global war on terrorism: 2001-2004

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

Circulating mitochondrial DAMPs cause inflammatory responses to injury.

The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial.

Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial.

Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial.

Thrombelastography/thromboelastometry.

Making sense of the preclinical literature on advanced hemostatic products.

Cumulative risks of early red blood cell transfusion.

The use of fresh whole blood in massive transfusion.

P2888

s00068-011-0150-1

P304

567-575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00068-011-0150-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26815467

http://www.w3.org/2001/XMLSchema#string